Harold H. Shlevin, Director of Galectin Therapeutics GALT, has filed 1 purchase and 14 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 06/29.

HS

HS

Harold H. Shlevin

Director

Company

Galectin Therapeutics GALT

First filing

23/01/30

Trades

42 trades

Buys / sales

1 / 14

12-month net buying

−$1.6M

Last trade

06/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	06/26–06/29	06/30	30,000 sh2 trades	$5.03avg.	$150,890.72	−82.2%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/12/17	25/12/19	24,499 sh2 trades	$7.04avg.	$172,472.96	−79.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/12/12–25/12/15	25/12/16	28,210 sh2 trades	$6.28avg.	$177,129.21	−71.6%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/12/08–25/12/09	25/12/10	175,790 sh8 trades	$6.00avg.	$1,055,413.3	−94.0%
Galectin TherapeuticsGALT	Open-market buy	24/12/30	24/12/31	6,500 sh	$1.16	$7,540	+74.7%